Readers And Tweeters Are Buzzing Over ‘Bill Of The Month’
A crowdsourced investigation by KHN and NPR gives voice to those who are puzzled and outraged by medical invoices.
Search
Filter
6,841 - 6,860 of 15,443 Results
-
-
Choosing Between Death And Deportation
What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives. And even in states with generous care for a dire illness, a patient can face difficult life-and-death choices.
-
Vermont Legislators Pass A Drug Importation Law. So What?
The first-in-the-nation measure would empower Vermont to set up a wholesale program to import prescription drugs from Canada. But it still will have to get federal buy-in before it is operational.
-
Podcast: KHN’s ‘What The Health?’ Much Ado About Drug Prices
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call discuss President Donald Trump’s proposals to control prescription drug prices and the efforts to sell the plan to lawmakers and the public. Also, Rovner interviews emeritus law professor Timothy Jost about the state of the Affordable Care Act.
-
What Explains The Rising Overdose Rate Among Latinos?
Opioid addiction is often portrayed as a white problem, but overdose rates are now rising faster among Latinos and blacks. Cultural and linguistic barriers may put Latinos at greater risk.
-
California’s Deadly STD Epidemic Sets Record
Rates of gonorrhea, syphilis and chlamydia in California have shot up 45 percent over five years, resulting in 30 syphilis-related stillbirths in 2017 alone, new state data show.
-
California Hospital Giant Sutter Health Faces Heavy Backlash On Prices
In a case with possible national repercussions, the state’s attorney general has sued over alleged price gouging, and other legal and legislative challenges are afoot. Sutter is pushing back hard, denying anticompetitive behavior.
By Chad Terhune -
Reversing An Overdose Isn’t Complicated, But Getting The Antidote Can Be
Last month, U.S. Surgeon General Jerome Adams urged more Americans to carry and learn to use naloxone, which can save someone from an opioid overdose. But the drug, brand-name Narcan, can be difficult to get and expensive.
-
Lack Of Insurance Exposes Blind Spots In Vision Care
As many as 16 million people in the United States have undiagnosed or uncorrected vision problems that could be fixed with eyeglasses, contact lenses or surgery.
-
Will We Still Be Relevant ‘When We’re 64’?
Older adults often feel invisible as their interactions with younger people dwindle and hardly anyone seems to seek their advice. To make matters worse, studies link loneliness to weaker immune systems and poorer physical health.
-
Sticker Shock Jolts Oklahoma Patient: $15,076 For Four Tiny Screws
A woman with foot pain was floored by the high cost of titanium screws used in her surgery. “Unless the metal [was] mined on an asteroid, I do not know why it should cost that amount,” she says.
By Liz Szabo -
L.A. County Unlawfully Terminated Thousands Of Medi-Cal Recipients, Court Rules
A judge orders the county to fix problem that harmed low-income seniors and people with disabilities, including those with serious health conditions.
By Anna Gorman -
First, Marijuana. Are Magic Mushrooms Next?
Advocates in Oregon and Denver are pushing ballot measures to allow possession of mushrooms containing the hallucinogenic ingredient psilocybin, as new research shows it may be useful in treating depression and anxiety. Supporters of a measure to decriminalize magic mushrooms in California ended their effort late last month.
-
Trump Vows (Again) To Lower Drug Prices But Skeptics Doubt Much Will Change
President Donald Trump’s much-awaited speech about slashing drug costs was long on rhetoric but short on specifics that will reduce prices.
By Sarah Jane Tribble and Liz Szabo -
Best Reads Of The Week With Brianna Labuskes
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
-
Why Did Novartis Pay Trump’s Lawyer $1.2 Million? Look At Its Drug Prices
Promises to control pharma prices threaten profits for Switzerland-based Novartis, which sells some of the costliest drugs in the world.
By Jay Hancock -
Consumers Brace For Premium Hikes While Lawmakers Grasp At Remedies
Health insurers’ initial premium requests indicate stiff price hikes for consumers, just as bipartisan talks in Congress fall flat.
By Julie Rovner -
Under Trump Proposal, Lawful Immigrants Might Be Inclined To Shun Health Benefits
A proposed change in immigration policy from the Trump administration could make it more difficult for immigrants to obtain a green card if family members use Medicaid or other government benefits for medical care.
-
Living Apart Together: A New Option for Older Adults
Why older couples in supportive, loving, long-term relationships decide to live apart and not get married.
-
Podcast: KHN’s ‘What The Health?’ The Politics Of Rising Premiums And Menu Labeling
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Margot Sanger-Katz of The New York Times and Anna Edney of Bloomberg News discuss the latest on the politics of rising premiums, GOP efforts to take back money from the Children’s Health Insurance Program, and the controversy over new rules requiring calorie information on menus. Plus for extra credit, the panelists recommend their favorite health stories of the week.